- Home
- CRDL vs BTM Comparison
CRDL vs BTM Comparison
Compare CRDL & BTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- BTM
- Stock Information
- Founded
- CRDL 2017
- BTM 2016
- Country
- CRDL Canada
- BTM United States
- Employees
- CRDL N/A
- BTM N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- BTM Finance: Consumer Services
- Sector
- CRDL Health Care
- BTM Finance
- Exchange
- CRDL Nasdaq
- BTM Nasdaq
- Market Cap
- CRDL 126.5M
- BTM 144.5M
- IPO Year
- CRDL N/A
- BTM N/A
- Fundamental
- Price
- CRDL $1.31
- BTM $4.07
- Analyst Decision
- CRDL Strong Buy
- BTM Strong Buy
- Analyst Count
- CRDL 2
- BTM 2
- Target Price
- CRDL $9.00
- BTM $6.00
- AVG Volume (30 Days)
- CRDL 1.2M
- BTM 1.0M
- Earning Date
- CRDL 08-26-2025
- BTM 08-12-2025
- Dividend Yield
- CRDL N/A
- BTM N/A
- EPS Growth
- CRDL N/A
- BTM N/A
- EPS
- CRDL N/A
- BTM N/A
- Revenue
- CRDL N/A
- BTM $608,432,000.00
- Revenue This Year
- CRDL N/A
- BTM $10.59
- Revenue Next Year
- CRDL N/A
- BTM $4.27
- P/E Ratio
- CRDL N/A
- BTM N/A
- Revenue Growth
- CRDL N/A
- BTM N/A
- 52 Week Low
- CRDL $0.77
- BTM $0.93
- 52 Week High
- CRDL $2.63
- BTM $6.88
- Technical
- Relative Strength Index (RSI)
- CRDL 51.92
- BTM 33.32
- Support Level
- CRDL $0.94
- BTM $4.02
- Resistance Level
- CRDL $1.55
- BTM $4.68
- Average True Range (ATR)
- CRDL 0.13
- BTM 0.30
- MACD
- CRDL -0.00
- BTM -0.11
- Stochastic Oscillator
- CRDL 59.74
- BTM 3.62
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About BTM Bitcoin Depot Inc.
Bitcoin Depot Inc owns and operates the widest network of BTMs across North America where customers can buy and sell Bitcoin. Bitcoin Depot helps power the digital economy for users of cash. It has locations across the U.S. and Canada at, among others, the following types of retailers: Convenience Stores and Gas Station Chains, Pharmacies and Grocers and Mall Operators.